Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

Innate Pharma - Filing #882171

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
45 478 EUR
829,000 EUR
Revenue
24 703 EUR
69 773 EUR
Profit (loss) from discontinued operations
7 331 EUR
63 155 EUR
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
58 457 EUR
51 767 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
917,000 EUR
13 370 EUR
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
26 818 EUR
1 177 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.